VIKING GLOBAL INVESTORS LP
- SEC CIK
- 0001103804
Latest role at each company
- INBX Inhibrx Biosciences, Inc.10% Owneras of Oct 9, 2025
- BBIO BridgeBio Pharma, Inc.10% Owneras of Jul 1, 2025
- APG APi Group Corp10% Owneras of Jun 18, 2024
- CIK 000173961410% Owneras of Jun 3, 2024
- CIK 000182536710% Owneras of Feb 28, 2024
Show 8 more companies
- FDMT 4D Molecular Therapeutics, Inc.10% Owneras of Jan 5, 2024
- ROIV Roivant Sciences Ltd.10% Owneras of Jun 26, 2023
- CIK 000182832610% Owneras of Nov 25, 2022
- RLYB Rallybio Corp10% Owneras of Nov 17, 2022
- AMLX Amylyx Pharmaceuticals, Inc.10% Owneras of Sep 9, 2022
- PRCT PROCEPT BioRobotics Corp10% Owneras of Mar 22, 2022
- DNA Ginkgo Bioworks Holdings, Inc.10% Owneras of Mar 4, 2022
- FIGS FIGS, Inc.10% Owneras of Sep 3, 2021
Trades
Every Form 4 that lists VIKING GLOBAL INVESTORS LP as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Oct 9, 20254:41 PM ET | Oct 7, 2025 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −350K | $32.25 | −$11.29M | 102.86K | −77.3% | SEC |
| BBIOBridgeBio Pharma, Inc. | Jul 1, 20257:48 PM ET | Jun 27, 2025 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −3.5M | $44.00 | −$154M | 18.56M | −15.9% | SEC |
| BBIOBridgeBio Pharma, Inc. | Jan 31, 20257:18 PM ET | Jan 31, 2025 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −3.07M | $34.90 | −$106.99M | 22.06M | −12.2% | SEC |
| APGAPi Group Corp | Jun 18, 20245:05 PM ET | Jun 17, 2024 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −1.95M | $38.15 | −$74.46M | 0 | −100.0% | SEC |
| APGAPi Group Corp | Jun 18, 20245:04 PM ET | Jun 17, 2024 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | SSaleCommon Stock | −1.95M | $38.15 | −$74.46M | 0 | −100.0% | SEC |
| APGAPi Group Corp | Mar 7, 20244:44 PM ET | Mar 5, 2024 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −3.04M | $34.25 | −$104.07M | 39.03K | −98.7% | SEC |
| APGAPi Group Corp | Mar 7, 20244:43 PM ET | Mar 5, 2024 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | SSaleCommon Stock | −3.04M | $34.25 | −$104.07M | 39.03K | −98.7% | SEC |
| FDMT4D Molecular Therapeutics, Inc. | Jan 5, 20245:44 PM ET | Jan 4, 2024 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −540K | $19.53 | −$10.55M | 4.25M | −11.3% | SEC |
| APGAPi Group Corp | Jan 4, 20244:15 PM ET | Jan 2, 2024 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −6.5M | $31.30 | −$203.45M | 17.09K | −99.7% | SEC |
| APGAPi Group Corp | Jan 4, 20244:11 PM ET | Jan 2, 2024 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | SSaleCommon Stock | −6.5M | $31.30 | −$203.45M | 17.09K | −99.7% | SEC |
| – | Sep 21, 20235:00 PM ET | Sep 19, 2023 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +1.39M | $18.00 | +$25M | 1.74M | +391.6% | SEC |
| – | Sep 21, 20234:59 PM ET | Sep 19, 2023 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +1.39M | $18.00 | +$25M | 1.74M | +391.6% | SEC |
| – | Aug 30, 20238:44 PM ET | Aug 28, 2023 | VIKING GLOBAL INVESTORS LP and 5 others10% Owner | PPurchaseCommon Stock | +511.63K | $19.35 | +$9.9M | 511.63K | New position | SEC |
| – | Aug 30, 20238:44 PM ET | Aug 28, 2023 | VIKING GLOBAL INVESTORS LP and 5 others10% Owner | PPurchaseCommon Stock · Derivative | +1.04M | $19.3499 | +$20.1M | 1.04M | – | SEC |
| BBIOBridgeBio Pharma, Inc. | Jul 19, 20239:33 PM ET | Jul 18, 2023 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Stock | −1.5M | $35.00 | −$52.5M | 25.12M | −5.6% | SEC |
| ROIVRoivant Sciences Ltd. | Jun 26, 20235:11 PM ET | Jun 22, 2023 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | SSaleCommon Shares | −13M | $9.90 | −$128.7M | 12.88M | −50.2% | SEC |
| FDMT4D Molecular Therapeutics, Inc. | May 11, 20235:50 PM ET | May 9, 2023 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +850K | $16.00 | +$13.6M | 4.79M | +21.6% | SEC |
| RLYBRallybio Corp | Nov 17, 20224:30 PM ET | Nov 15, 2022 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock · Derivative | +3.33M | $5.9999 | +$20M | 3.33M | – | SEC |
| – | Nov 4, 20226:17 PM ET | Nov 2, 2022 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +847.06K | $10.08 | +$8.54M | 1.21M | +232.4% | SEC |
| – | Oct 12, 20224:39 PM ET | Oct 7, 2022 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +1.33M | $29.9999 | +$40M | 333.33K | New position | SEC |
| AMLXAmylyx Pharmaceuticals, Inc. | Sep 9, 20229:48 PM ET | Sep 8 – Sep 9, 2022 | VIKING GLOBAL INVESTORS LP and 8 others10% Owner | SSaleCommon Stock | −1.4M | $29.7997 | −$41.72M | 1.85M | −43.1% | SEC |
| PRCTPROCEPT BioRobotics Corp | Mar 22, 20228:51 PM ET | Mar 18, 2022 | VIKING GLOBAL INVESTORS LP and 8 others10% Owner | SSaleCommon Stock | −1.25M | $29.90 | −$37.35M | 298.21K | −80.7% | SEC |
| AMLXAmylyx Pharmaceuticals, Inc. | Jan 13, 20229:05 PM ET | Jan 11, 2022 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +2.3M | $19.00 | +$43.7M | 2.3M | New position | SEC |
| APGAPi Group Corp | Jan 5, 20228:20 PM ET | Jan 3, 2022 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | PPurchaseCommon Stock · Derivative | +8.13M | $24.60 | +$200M | 4K | – | SEC |
| PRCTPROCEPT BioRobotics Corp | Sep 21, 20214:27 PM ET | Sep 17, 2021 | VIKING GLOBAL INVESTORS LP and 7 others10% Owner | PPurchaseCommon Stock | +400K | $35.00 | +$14M | 400K | New position | SEC |
| FIGSFIGS, Inc. | Sep 3, 20217:28 PM ET | Sep 2 – Sep 3, 2021 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | SSaleClass A Common Stock | −200K | $46.7795 | −$9.36M | 14.74M | −1.3% | SEC |
| RLYBRallybio Corp | Aug 2, 20218:40 PM ET | Jul 29, 2021 | VIKING GLOBAL INVESTORS LP and 6 others10% Owner | PPurchaseCommon Stock | +806K | $13.00 | +$10.48M | 4.19M | +23.8% | SEC |